Main navigation

deMauri Mackie

Class 2008
Education BA, University of Pennsylvania

Dr. Joel Pomerantz

Current Position Fellowship in Clinical Research Methodology

Worldwide Clinical Trials

Research Interests

High-Throughput Screen for Modulators of Oncogenic CARD11 Signaling

CARD11 is a multi-domain scaffold protein whose function is required for regulated NF-kappaB activation during the adaptive immune response. Several hyperactive mutations have been identified in Diffuse Large B-Cell Lymphoma (DLBCL). While some of these oncogenic mutants selectively recruit known co-factors of CARD11 such as Bcl-10, others fail to recruit these co-factors. Using a high-throughput screen, we are identifying previously unknown co-factors of oncogenic CARD11 which may modulate its activity during the adaptive immune response.


Pedersen SM, Chan W, Jattani RP, Mackie dS, Pomerantz JL.  Negative Regulation of CARD11 Signaling and Lymphoma Cell Survival by the E3 Ubiquitin Ligase RNF181.  Mol Cell Biol. 2015 Dec 28;36(5):794-808. doi: 10.1128/MCB.00876-15.PMID:26711259